Systematic (IUPAC) name | |
---|---|
N-(3-methylphenyl)-2-(4-pyridin-2-ylpiperidin-1-yl)acetamide | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
ATC code | ? |
PubChem | CID 10425450 |
ChemSpider | 8600878 |
ChEMBL | CHEMBL375596 |
Chemical data | |
Formula | C19H23N3O |
Mol. mass | 309.405 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
A-412,997 is a drug which acts as a dopamine agonist that is used in scientific research. It is the first drug developed that is a highly selective agonist for the D4 subtype, with significantly improved selectivity over older D4-preferring compounds such as PD-168,077 and CP-226,269.[1] In animal tests it improved cognitive performance in rats to a similar extent as methylphenidate, but without producing place preference or other signs of abuse liability.[2][3] Also unlike other dopamine agonists, selective D4 agonists do not cause side effects such as sedation and nausea, and so might have advantages over older dopamine agonist drugs.[4]